Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06880705 · ClinicalTrials.gov registry record · NA
The Trans-Led Care Study
A NA study of Substance Abuse and Human Immunodeficiency Virus (HIV), sponsored by Illinois Institute of Technology.
- Recruiting
- Registry status
- NA
- Development phase
- 124
- Enrollment target
- 1
- Study location
NCT06880705: Recruiting NA study of Substance Abuse and Human Immunodeficiency Virus (HIV), sponsored by Illinois Institute of Technology.
NCT06880705 is a NA study of Substance Abuse and Human Immunodeficiency Virus (HIV) that is actively recruiting participants, run by Illinois Institute of Technology. The registered enrollment target is 124 participants, below the 5,258-participant average among 58 other Substance Abuse trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06880705, a NA study of Substance Abuse and Human Immunodeficiency Virus (HIV), is actively recruiting participants, sponsored by Illinois Institute of Technology.
- RECRUITING
- Registry status
- NA
- Development phase
- 124 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is testing a new mutual-help group called "the TLC program" for transgender adults who use substances or are recently in recovery. The TLC Program is based on Acceptance and Commitment Therapy or "ACT" which is a type of mental health counseling that focuses on using mindfulness skills to connect a person to their values and improve their mental health. The TLC Program was developed by transgender and gender diverse community members, mental health providers, and researchers.
Primary Outcome
Minimum value = 0, Maximum value = 1, Higher score = worse outcome
Conditions Studied
Interventions
- BEHAVIORAL The TLC Program
Study Locations (1)
Illinois
- Illinois Institute of Technology - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2025-02-10 |
| Est. Completion | 2027-07-31 |
| Phase | NA |
What NCT06880705 shows while recruiting
NCT06880705 is an interventional study that assigns participants to a tested intervention. The registered 124 participants enrollment target is mid-sized for trials with a published cap, below the 5,258-participant average among 58 other Substance Abuse trials with a reported enrollment target (98% lower).
The record links to 5 conditions, with Substance Abuse appearing as the primary indexed condition, and to 1 intervention - of which The TLC Program is the first listed.
NCT06880705 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06880705 about?
NCT06880705 is a clinical study titled "The Trans-Led Care Study". This study is testing a new mutual-help group called "the TLC program" for transgender adults who use substances or are recently in recovery. The TLC Program is based on Acceptance and Commitment Therapy or "ACT" which is a type of mental health counseling that focuses on using mindfulness skills to...
What is the current status of trial NCT06880705?
This trial is currently recruiting. It is a NA study. The enrollment target is 124 participants. The study started on 2025-02-10. Estimated completion is 2027-07-31.
What conditions does trial NCT06880705 study?
This clinical trial studies the following conditions: Substance Abuse, Human Immunodeficiency Virus (HIV), Substance Use Disorder (SUD), Substance Use (Drugs, Alcohol), Substance Addiction.
What interventions are being tested in trial NCT06880705?
The interventions under investigation include: The TLC Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT06880705?
This trial is sponsored by Illinois Institute of Technology, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06880705 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06880705's enrollment target sits among peer trials
124 33rd of 58 higher than 26 of 58 other Substance Abuse trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Abuse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Functional Connectivity Alterations in Suicidal Patients Among Opioid Users
RECRUITING · NA
-
Testing ALERT With GTO in Middle Schools
RECRUITING · NA
-
Testing Strategies to Improve Substance Misuse Prevention Research Use in State Policy Contexts
RECRUITING · NA
-
The STop UNhealthy Substance Use Now Trial
RECRUITING · NA
-
Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prevention
RECRUITING · NA
-
SER Familia: A Family-Based Intervention Addressing Syndemic Conditions Among Latino Immigrant Families
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523014 · 124 participants · Phase 2
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- NCT02670707 · 124 participants · Phase 3
Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
- NCT02830724 · 124 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
- NCT04748809 · 124 participants · NA
Effect of Anti-inflammatory Diet in Rheumatoid Arthritis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI